Nasopharyngeal Cancer (NPC)
*Links on this page will take you to content on the cancer.net website. Links will open in a new window.
Nasopharyngeal cancer (also called nasopharyngeal carcinoma or NPC) is a disease of the nasopharynx, which is the air passageway at the upper part of the pharynx (throat) behind the nose. The pharynx is a hollow tube approximately five inches long that starts behind the nose and ends on top of the larynx (or voice box) and esophagus (the swallowing tube that goes from the throat to the stomach). The nostrils lead through the nasal cavity into the nasopharynx, and an opening on each side of the nasopharynx (called the Eustachian tube opening) leads into the middle ear on each side.
Cancer begins when cells in the body become abnormal and multiply without control or order. These cells form a growth of tissue, called a tumor. A tumor can be benign (noncancerous) or malignant (cancerous).
There are several types of benign nasopharyngeal tumors, including angiofibromas and hemangiomas that involve the vascular or blood-carrying system, and tumors in the lining of the nasopharynx that include the minor salivary glands.
A malignant nasopharyngeal tumor is cancerous and can invade and damage healthy tissues and organs in other parts of the body. The nasopharynx contains several types of tissue, and each contains several types of cells. Different cancers can develop in each kind of cell. The differences are important because they determine the seriousness of the cancer and the type of treatment needed. According to the World Health Organization (WHO), NPC is classified into three subtypes:
- Keratinizing squamous cell carcinoma (WHO type 1)
- Nonkeratinizing squamous cell carcinoma (WHO type 2)
- Undifferentiated or poorly differentiated carcinoma, including lymphoepithelioma and anaplastic variants (WHO type 3). Many types of nasopharyngeal cancer contain white blood cells, and these lymphocytes give it the name of lymphoepithelioma. (See more details about differentiation in the Staging section.)
head and neck cancer.
Back to top
Nasopharyngeal cancer is uncommon in the United States, with about 2,000 people diagnosed each year. In the last few years, the rate at which Americans have been developing this cancer has been slowly decreasing. NPC is much more common in other parts of the world, such as Asia and North Africa; for instance, in Southeast China it is a fairly common cancer.
Cancer statistics should be interpreted with caution. Estimates are based on data from thousands of cases of this type of cancer in the United States each year, but the actual risk for a particular individual may differ. It is not possible to tell a person how long he or she will live with nasopharyngeal cancer.
Source: American Cancer Society.
Back to top
Additional information *
- Medical Illustrations
- Risk Factors and Prevention
- Staging With Illustrations
- Side Effects
- After Treatment
- Current Research
- Questions to Ask the Doctor
- Patient Information Resources
- Clinical Trials Resources
Oncology®. All rights reserved. www.cancer.net.